Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 January 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date

Pirmdiena, 8 Janvāris 2024, Visu dienu
Ceturtdiena, 11 Janvāris 2024, Visu dienu

Vieta

European Medicines Agency, Amsterdam, the Netherlands

Documents

Share this page